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Background: Previous studies during SARS and Ebola pandemics have shown
that quarantine is associated with several negative psychological effects, such as
post-traumatic stress symptoms, confusion, and anger. These conditions may affect the
course of many diseases, including migraine. Although it is possible that the quarantine
measures for the current COVID-19 pandemic affect migraine burden, no information is
currently available on this issue.
Aim: In this study, we aimed to: (1) explore the possible changes in migraine frequency,
severity, and days with acute medication intake during quarantine period; (2) evaluate
possible differences in migraine outcomes in consideration of lifestyle changes, emotions,
pandemic diffusion, and COVID-19 infection.
Methods: We interviewed patients who were included in the observational
Italian Headache Registry (Registro Italiano Cefalee, RICE), retrospectively collecting
information on main headache features, lifestyle factors, emotions, individual infection
status, and perception of COVID-19 for 2 months before (pre-quarantine) and after the
beginning of the quarantine (quarantine). Inclusion criteria were: age > 18, diagnosis of
migraine without aura, migraine with aura and chronic migraine, last in-person visit more
than 3 months preceding the beginning of quarantine.
Results: A total of 433 migraine subjects agreed to be interviewed. We found an
overall reduction in headache frequency (9.42 ± 0.43 days with headache vs. 8.28 ±
0.41) and intensity (6.57 ± 0.19 vs. 6.59 ± 0.21) during the quarantine, compared to
pre-quarantine. There was a correlation between improvement and number of days of
stay-at-home. When results were stratified for geographic area, we found a tendency
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toward worsening of headache frequency in northern Italy. Disgust regarding viral
infection corresponded to a minor improvement in migraine.
Conclusions: Migraine patients showed a mild improvement of migraine features,
probably attributable to resilient behavior toward pandemic distress. Disgust regarding
the contagion whereas potentially favoring defensive behavior, could potentially worsen
migraine. The spontaneous limitation of migraine burden during quarantine could
favor patient follow-up via the use of telemedicine visits, reliable diaries, and frequent
remote contacts.
Keywords: migraine, COVID-19, lockdown, resilience, disgust
INTRODUCTION
COVID-19 (1, 2) was declared a global pandemic on March 11,
2020 by the World Health Organization. Italy, the first European
country in which there was an outbreak of the pandemic,
currently records a total of ∼185,000 confirmed cases and more
than 24,000 patients with severe illness. The spread of COVID-
19 in the Italian territory was markedly different, with northern
Italy showing amuch higher number of cases compared to central
and southern Italy. On March 10, the Italian government was the
first in Europe to impose severe social-distancing orders. Social-
distancing and mitigation strategies (3–5) aim to defer a major
flow of patients and reduce the demand for hospital admissions
while safeguarding the most vulnerable subjects (6).
Studies related to the 2003 outbreak of severe acute respiratory
syndrome (SARS) in China and Canada, as well as the 2014
Ebola outbreak in Africa, reported that quarantine is associated
with several negative psychological effects, such as post-traumatic
stress symptoms, confusion, and anger (7, 8), with a potential
increase in suicidal risk (9). Changes in social behavior and
work activities, the unavailability of a public health system for
routine medical management, and widespread fear of infection
could cause important psychosocial outcomes (10–13), and could
dramatically increase the burden of the disease. However, few
data have been reported on the impact on migraine caused
by psychosocial distress due to COVID-19 and long-term
distancing measures.
In this study, we aimed to (1) explore whether the quarantine
period affected the frequency and severity of migraine and
days with acute medication intake, and (2) evaluate possible
differences in migraine outcomes in consideration of changes in
lifestyle, emotions, pandemic diffusion, andCOVID-19 infection.
METHODS
Study Population and Design
This observational cross-sectional study describes the impact
of the COVID-19 pandemic and social distancing measures on
headache features in migraine patients. It was conducted via a
structured telephone interview in a sample of patients included in
the Italian Registry of Headache (Registro Italiano delle Cefalee,
Abbreviations: RICe, Registro Italiano Cefalee- Italian Headache Registry; SISC,
Società Italiana Studio Cefalee-Italian Society for Headache Study.
RICe), which enrolls patients aged≥ 18 years who visit headache
treatment centers.
RICe is an observational registry promoted and endorsed by
the Italian Society for the Study of headaches (SISC), which
records clinical data of consecutive patients with headache who
refer to the member Headache Centers. The present ancillary
sub-study is based on data from seven headache centers in
northern (Pavia and Turin), central (Florence and Latina), and
southern (Avezzano-L’Aquila, and two centers in Bari) that
enrolled patients who had entered the RICe at least 3 months
before the start of the quarantine (pre-quarantine) in Italy. The
seven centers are located in geographical areas that experienced
markedly different impacts of the COVID-19 outbreak: higher
in the north, medium central, and lower in southern Italy
(2020- http://www.protezionecivile.gov.it/attivita-rischi/rischio-
sanitario/emergenze/coronavirus). All the patients admitted to
the RICe study were requested to complete a headache diary,
reporting the occurrence and intensity of headache (from 1 -
mild to 10- the most severe headache), and use of symptomatic
drugs. For the present study, the inclusion criteria were age
≥ 18 years, a diagnosis of migraine without aura, migraine
with aura and chronic migraine according to the criteria of the
International Classification of Headache Disorders, III edition
(ICHD-III) (14), and the most recent in-person visit within the 3
months preceding the lockdown period. Exclusion criteria were
ascertained comorbidity with other forms of primary headaches,
psychiatric disorders according to DSMV, and liver, kidney, and
heart insufficiency.
Telephone Interviews and Variables of
Interest
Telephone interviews were carried out by study investigators
between March 27 and April 18, 2020. The interview was
a web-supported questionnaire to be completed during the
telephone call. The questionnaire was administered in the
Italian language (it is available in Italian and English in the
Supplementary Material). Variables of interest included
frequency of headache expressed as average number of headache
days per month, calculated during the 2 months preceding
the quarantine (pre-quarantine) and in the time from the
beginning of the quarantine (March 8, 2020 for Northern
Italy, extended on March 10, 2020 to the rest of Italy). Patients
were asked to report the intensity of headache and the use of
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symptomatic drugs during the pre-quarantine and quarantine
times, according to their headache diaries. Questions included
the following: number of days of staying at home, current
working conditions, level of risk contacts, individual infection,
personal feelings on how COVID-19 affects migraine outcomes
and/or migraine as a possible risk factor for COVID-19, fear
of becoming infected, possible changes in daily behaviors
(food intake habits, alcohol consumption, and sleep quality)
as a result of social-distancing measures, main sensations
regarding the pandemic emergency (anger, fear, disgust, anxiety,
sadness, happiness) on a scale from 0 (no emotion) to 10
(maximum emotion), and subjective evaluation of mood change
(worsening, no change, improvement) (see the questionnaire in
the Supplementary Section). The questionnaire was developed
taking into consideration the headache features reported in the
diaries. For questions related to the pandemic, we used ad-hoc
and not previously validated scales on the possible changes of
fundamental emotions, psychological reactions, and habits due
to pandemic. A similar survey was used on the general Italian




Study outcomes were headache frequency and intensity
and days with acute medication intake during the 8 weeks
preceding and during the social-distancing measures. Predictor
variables were migraine severity before the quarantine,
lifestyle habits, emotions, severity of pandemic diffusion,
and COVID-19 infection.
Ethics
The local ethics committees of each recruiting center approved
the RICe registry, and patients enrolled signed an informed
consent, which included the possibility to perform sub-studies on
their headache features.
Statistical Analysis
In the absence of previous similar reports and because of
the descriptive nature of the study, the sample size was not
calculated. The parametric distribution of the data was evaluated
by the Levene test for equality of variance. As the observation
period during quarantine varied across subjects, we normalized
headache days for the effective period of observation (number
of headache days / number of total days of observation × 30).
We used ANOVA for repeated measures with condition before
vs. during social distancing as factors. The effect of severity
of migraine before quarantine, emotions, living behavior, and
geographic area on primary outcomes was evaluated by the
same repeated measures ANOVA model, introducing nominal
variables as factors and quantitative variables as covariates. A
complete factorial ANOVA model type III included in IBM SPSS
software version 21 was used.
RESULTS
Demographic Data, Working Status, Living
Conditions, and Daily Habits
General
A total of 433 migraine subjects agreed to be interviewed,
while 10 patients did not give their consent. The mean interval
elapsed between the start of the quarantine and the time of the
interview was 31.9 ± 4.5 days without significant differences
across participating centers. The baseline characteristics of the
enrolled patients are presented in Table 1.
Most of the interviewed patients did not report changes in
food intake, sleep, or alcohol consumption (Table 1). During
quarantine, 177 subjects (55.1%) reported worsening, 42 (13.1%)
no change, and 102 (31.8%) improvement in mood. Emotions
scores related to pandemic are reported in Table 1.
Migraine During Quarantine
A reduction in the average number of days with headache
(9.42 ± 0.43 before quarantine, 8.28 ± 0.41 during quarantine),
days with acute medication intake (10.21 ± 0.96 before;
10.79 ± 1.02 during), and migraine intensity (6.57 ± 0.19
before; 6.59 ± 0.21 during) was observed during quarantine
compared to pre-quarantine (Table 2). Most patients subjectively
reported that their migraines did not change after the start
of quarantine. Most migraine patients did not consider
migraine as a facilitating factor for COVID-19 infection
(Supplemental Table 1). Two hundred eighty-nine patients were
taking preventive treatments for migraine; 88 discontinued
treatment for different reasons, such as drug failure or difficulty
in attaining the drugs (Supplemental Table 2).
Effects of Migraine Severity, Lifestyle Habits,
Emotions, and Severity of Pandemic Diffusion on
Headache Frequency
Before quarantine, 331 patients reported episodic migraine, while
the remainder were affected by chronic migraine. Improvements
in headache frequency and analgesic consumption were higher
in chronic patients than in episodic migraine patients (Table 2).
Alcohol use, smoking, eating, and subjective perception of
sleep quality did not affect headache frequency and intensity,
use of symptomatic drugs, and/or working conditions. The
improvement of headache frequency correlated with the number
of stay-at-home days (ANOVA with repeated measures with
days of social distancing as covariate F 37.07 p < 0.0001).
Changes in headache parameters were similar among patients
living in different urban areas and with different levels of
education. Migraine features were not significantly different
among northern, central and southern Italy before the quarantine
period (Supplemental Table 3). However, patients in northern
Italy, the geographical area with the highest pandemic diffusion,
showed a tendency of increased headache frequency and use of
acute medication (Table 3; Figure 1). It should be noted that the
number of days of effective stay-at-home was reduced in patients
from northern Italy (Supplemental Table 3).
There was a significant relationship between disgust
against COVID-19 infection and an increase in headache
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Age (years), mean ± SE 43.97 ± 0.63
BMI, mean ± SE 24.1 ± 0.002





Days of social distancing, mean ± SE 29.27 ± 0.58
Home place, n (%)
Countryside 76 (17.8)
City 183 (42.3)
Small town 174 (40.2)
No. of cohabiting family members during social






Work from home 89 (20.6)
At workplace 48 (11.1)
Unemployed (lost position) 88 (20.3)












Emotional reaction, mean ± SE
Anger 4.15 ± 0.27
Disgust 3.39 ± 0.27
Fear 5.71 ± 0.28
Anxiety 5.86 ± 0.18
Sadness 5.40 ± 0.28
Happiness 4.67 ± 0.23
BMI indicates body mass index.
Intensity of emotions related to the COVID-19 emergency are reported on a 0–10 scale.
frequency (repeated measures ANOVA with disgust as covariate
F 6.43 p 0.004).
Patients reporting mood improvement showed a tendency
toward reduced headache frequency (repeatedmeasures ANOVA
with mood perception as factor: F 5.43 p 0.001). However,
the Bonferroni test among the different mood perceptions did
not show any significant difference. Patients who subjectively
reported a worsening of their migraine showed an objective
increase in headache frequency (repeatedmeasures ANOVAwith
subjective impression of migraine severity as factor: F 35.58 p
< 0.0001: Bonferroni test: got worse vs. improved p < 0.01).
However, patients feeling migraine as a facilitating factor for
infection showed a tendency toward frequency increase (ANOVA
with perception of migraine as risk factor: F 3.59 p 0.012
Bonferroni test: n.s.). Emotions against pandemic and subjective
perception of mood and disease severity did not influence the
change in headache features in chronic migraine compared to
episodic migraine.
COVID-19 Infection in Migraine Samples
In the overall sample, five patients reported having been infected
by SARS-CoV-2, two patients were asymptomatic, one had
recovered, and two were under treatment for mild pulmonary
symptoms that did not require hospitalization (Table 4). These
patients did not report substantial changes in their migraines
after infection.
DISCUSSION
The results of the present study show that migraine patients
had a mild improvement of headache frequency, days with acute
medication intake, and headache intensity during the social
distancingmeasures.Migraine improvement prevailed in chronic
patients in the areas where there was the lowest prevalence of
COVID-19, and was positively influenced by the number of days
of stay-at-home orders. Disgust toward infection corresponded
to an attenuation of headache improvement.
Migraine During Quarantine
The interview was conducted on migraine patients previously
enrolled in RICe, which guaranteed the presence of accurate
clinical features previously recorded. This represents a point
of strength compared to interviews administered to the
general population (16). The general improvement of headache
frequency and intensity during lockdown confirms results
obtained in smaller Italian migraine samples (17). Viral diffusion
may contribute to the onset of stress-related disorders (12, 18),
which may worsen migraine (19). The development of a resilient
behavior associated with COVID-19 (18) may have also involved
migraine patients. The American Psychological Association
(2014) defines resilience as “the process of adapting well in the
face of adversity, trauma, tragedy, threats, or even significant
sources of stress.” During a pandemic, resilient behavior could
reduce psychological distress (20). Although we did not apply a
specific questionnaire for resilience, a resilient mechanism could
help to improve the main features of migraine, such as frequency
in terms of days of headache per month and subjective feelings of
its intensity. In fact, resilience ability is generally associated with
better outcomes in patients with chronic pain (21).
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TABLE 2 | Comparison of headache features before and during lockdown period.
n◦ 433 Before During F P-value EM before n◦331 During CM before n◦102 During F P-value
Monthly headache days 9.42 ± 0.43 8.28 ± 0.41 60.6 <0.0001 5.10 ± 0.23 4.99 ± 0.35 21.6 ± 0.39 16.74 ± 0.59 59.6 <0.0001
Acute medication days 8.32 ± 0.51 7.19 ± 0.54 21.7 <0.0001 4.91 ± 0.46 4.2 ± 0.55 16.9 ± 0.78 13.2 ± 0.93 13.76 <0.0001
Headache intensity 6.93 ± 0.10 6.71 ± 0.11 6 0.014 6.79 ± 0.11 6.5 ± 0.12 7.25 ± 0.25 6.95 ± 0.19 0.1 n.s.
CM, Chronic Migraine patients; EM, Episodic Migraine patients. Data are reported as mean ± standard errors.
TABLE 3 | Comparison of headache features before and during lockdown period in the included patients.
North (n = 105) Center (n = 101) South (n = 227) F (geographic area) P-value P-value (Bonferroni)
Before During Before During Before During
Monthly headache days 10.57 ± 0.81 11.03 ± 0.78 8.19 ± 0.84 6.02 ± 0.80 9.50 ± 0.56 7.78 ± 0.53 6 0.003 <0.001 (South and
Center vs. North)
Acute medication days 10.21 ± 0.96 10.79 ± 1.02 7.29 ± 0.98 5.07 ± 1.04 7.46 ± 0.65 5.70 ± 0.69 3.6 0.027 <0.01 (South and
Center vs. North)
Headache intensity 6.57 ± 0.19 6.59 ± 0.21 7.25 ± 0.21 7.03 ± 0.22 6.96 ± 0.21 6.50 ± 0.14 3 0.05 NS
Data are reported as mean ± standard errors.
FIGURE 1 | Mean and standard errors of headache frequency, expressed in number of headache days for month, before and during the quarantine in the different
Italian geographic areas. Statistical analysis is reported in Table 3.
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TABLE 4 | Characteristics of migraine patients positive to SARS-CoV-2 infection.







Change in use of
symptomatic
drugs (%)
1 22 F South No −18 0.38 −75
2 56 F North No −20 1 0
3 47 F South Yes Under treatment −20 0.88 0
4 44 F North Yes Recovered −40 1 −32
5 46 F North Yes Under treatment −30 0.5 0
Changes refer to quarantine measures compared with the 2 previous months.
Effects of Migraine Severity, Lifestyle
Habits, Emotions, and Severity of
Pandemic Diffusion on Headache
Frequency
In a previous large global cross-sectional study, patients with
frequent migraine showed greater resilience in response to
negative events, such as treatment failures (22). The present
study suggests that mild improvement of migraine, probably
attributable to a resilient behavior against the pandemic,
could prevail in more severe migraines. Psychological features
of migraine patients, underlying a favorable outcome under
the current dramatic epidemics, were not recorded in the
RICe database upon previous visits, Although this could be
subject to further studies in a possible scenario of pandemic
persistence (23). A correlation between the emotional impact
of the pandemic situation and its effect on migraine features
was not found. However, the perception that migraine could
facilitate COVID-19 infection, possibly causing additional stress,
negatively affected the improvement of headache frequency. The
pandemic emergency did not seem to cause particular sleep
disruption in our migraine sample, an effect attributable to the
resilient reaction.
The improvement of headache severity was correlated with the
effective number of days of stay at home (24, 25). The resilient
behavior against migraine worsening for pandemic distress could
thus be enhanced during effective social distancing. We did
not find an association between headache improvement, work
activity, and lifestyle habits. Nevertheless, staying at home, even
if forced, could globally influence trigger factors and the ability
to rest, possibly decreasing the risk of recurrence. Environmental
factors could cause physical and psychological distress in normal
daily living, which would be attenuated during the quarantine.
The usual pace of life for work, exposure to weather changes, car
traffic, and travel, are recognized migraine stressors, and these
were obviously reduced in this unusual condition (26). This result
could be taken into consideration for the social management of
public health during pandemics (5).
The headache centers cooperating in data collection see
patients coming from different Italian regions, so we considered
the place of residence at the time of public restrictive measures.
Residents in regions with higher pandemic diffusion seemed to
express less resilient behavior. As an adjunctive result, we also
observed that patients in northern Italy reported fewer days of
social distancing, which were associated with a positive outcome
of migraine.We could thus suppose that the severity of pandemic
diffusion could change environmental situations and personal
habits (15) and exert an influence on resilient behavior.
The expression of disgust was slightly associated with
migraine frequency increase. Disgust is an emotional response
of rejection or revulsion to something potentially contagious or
offensive (27). It is a system that evolved to motivate infectious
disease avoidance and combat the behavioral causes of infectious
and chronic diseases, such as pandemic flu (28). While it could
help in assessing avoidance behavior during pandemic infections,
it is a cause of distress (28), which could have a negative impact
on migraine frequency and attenuate the resilient reaction.
COVID-19 Infection in Migraine Samples
Although the present study was not designed to assess the
frequency of infection in the migraine population, because
of the relatively small sample, we did find 5 out of 433
migraine patients positive for SARS-CoV-2 infection (1.15%).
At the time we collected data, there were ∼185,000 infected
individuals in the general Italian population (0.3%), with
a slight prevalence in males (51.7%) and a median age
of 62 years (Italian Healthy System and Civil Protection
report http://www.protezionecivile.gov.it/attivita-rischi/rischio-
sanitario/emergenze/coronavirus). However, the percentage of
asymptomatic persons among the general population is an
unresolved issue, so the present data do not enable any type
of speculation about the prevalence of SARS-CoV-2 infection
in migraine patients. Recent reviews about the main symptoms
of COVID-19 stated that headache occurs in nearly 10% of
patients, while migraine is not included within the comorbidities
that aggravate symptomatic patients (29). The three patients
presenting with symptoms of COVID-19 had a mild form,
which did not require hospitalization. They experienced the
same small improvement of headache symptoms as most of
the other patients. In the current literature, data on migraine
patients presenting with more severe symptoms of infection are
still lacking. Further studies and meta-analyses are needed to
establish the prevalence and clinical aspects of COVID-19 in the
migraine population.
Study Limitations
The main limitation of the present study is the small number
of patients interviewed. This limitation was determined by the
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restricted time window of the interview, limited to the time of the
restrictive measures, also termed “phase I,” enforced by the Italian
Government, and by the fact that enrolled cases were solely those
patients who had previously given their informed consent to the
RICe study and therefore could be enrolled in the present sub-
study. Additional limitations could be the scarce reliability of
headache diaries during the pandemic and the short amount of
time for evaluation of migraine outcome during the social and
health emergency (1 month on average). In fact, the consistency
of a retrospective report of headache frequency and patient habits
by telephone interview could be questionable. This study was
conducted in tertiary headache centers and included patients
with high monthly attack frequency who were not representative
of migraine in the general population. Finally, the interview text
and scales for emotional and psychological impact of pandemic,
were only partially validated among Italian citizens (15).
CONCLUSIONS
We found that, on average, migraine patients expressed a
reduction in migraine severity indices, probably due to resilient
behavior with regards to pandemic distress. The maintenance
of habitual lifestyles during social distancing was less evident
in people with a limited number of days of staying at home.
The present data could help in the future reorganization of
services, healthcare workforce, and ongoing management of
migraine (30). The spontaneous limitation of migraine burden
during quarantine could favor patient follow-up via the use of
telemedicine visits (12, 31), reliable diaries, and frequent remote
contacts after an initial in-person visit.
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